suramin has been researched along with neuropeptide y in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (75.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bültmann, R; Starke, K; von Kügelgen, I | 1 |
| Nickel, P; Schlicker, E; Urbanek, E | 1 |
| Kigoshi, S; Muramatsu, I; Oda, Y | 1 |
| Bültmann, R; Driessen, B; Kurz, AK; Starke, K; von Kügelgen, I | 1 |
| Rump, LC; von Kügelgen, I | 1 |
| Corsi, M; Palea, S; Ratti, E; Rimland, JM; Trist, DG | 1 |
| Donoso, MV; Huidobro-Toro, JP; Steiner, M | 1 |
| Howard, M; Huidobro-Toro, JP; Irarrázabal, MJ; Morán, S; Racchi, H; Zalaquett, R | 1 |
| Morris, JL | 1 |
| Bell, D; Bradley, E; Johnson, CD; Law, A | 1 |
| Hegg, CC; Jia, C; Kanekar, S | 1 |
| Fountain, SJ; Gonzalez-Montelongo, MDC | 1 |
12 other study(ies) available for suramin and neuropeptide y
| Article | Year |
|---|---|
Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Dioxanes; Drug Interactions; Idazoxan; Male; Mice; Muscle Contraction; Neuropeptide Y; Phenylephrine; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha; Suramin; Vas Deferens; Yohimbine | 1991 |
Antagonistic properties of four suramin-related compounds at vascular purine P2X receptors in the pithed rat.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Dose-Response Relationship, Drug; Male; Neuropeptide Y; Norepinephrine; Purinergic Antagonists; Rats; Rats, Inbred Strains; Suramin; Vasoconstrictor Agents | 1990 |
Evidence for sympathetic, purinergic transmission in the iris dilator muscle of the rabbit.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Electric Stimulation; Female; Guanethidine; In Vitro Techniques; Iris; Male; Muscle Contraction; Neuropeptide Y; Prazosin; Rabbits; Receptors, Purinergic; Suramin; Tetrodotoxin; Thionucleotides | 1994 |
Release of ATP in rat vas deferens: origin and role of calcium.
Topics: Adenosine Triphosphate; Adrenergic alpha-Agonists; Animals; Calcium; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neuropeptide Y; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Purinergic P2; Suramin; Vas Deferens | 1994 |
A study of ATP as a sympathetic cotransmitter in human saphenous vein.
Topics: Action Potentials; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Electric Stimulation; Female; Guanethidine; Humans; In Vitro Techniques; Male; Middle Aged; Neuropeptide Y; Norepinephrine; Receptors, Purinergic; Saphenous Vein; Suramin; Synaptic Transmission; Tetrodotoxin; Vasoconstriction | 1994 |
Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Cystamine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neuropeptide Y; Peptide Fragments; Prostate; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Suramin; Vas Deferens | 1995 |
BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Topics: Adenosine Triphosphate; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Arginine; Electric Stimulation; Mesenteric Arteries; Neuropeptide Y; Norepinephrine; Prazosin; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Suramin; Sympathetic Nervous System | 1997 |
Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Anti-Anxiety Agents; Arginine; Blood Vessels; Humans; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Prazosin; Purinergic Antagonists; Receptors, Neuropeptide Y; Receptors, Purinergic; Saphenous Vein; Suramin; Sympathetic Nervous System; Vasomotor System | 1999 |
Cotransmission from sympathetic vasoconstrictor neurons to small cutaneous arteries in vivo.
Topics: Adenosine Triphosphate; Animals; Arteries; Constriction, Pathologic; Electric Stimulation; Female; Guinea Pigs; Male; Neurons; Neuropeptide Y; Norepinephrine; Peptides, Cyclic; Skin; Suramin; Sympathetic Nervous System; Vasoconstriction | 1999 |
Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Arginine; Arteries; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Suramin; Sympathetic Nervous System; Synaptic Transmission; Tail; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Purinergic receptor activation evokes neurotrophic factor neuropeptide Y release from neonatal mouse olfactory epithelial slices.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Animals, Newborn; Collodion; Immunoassay; Immunohistochemistry; In Vitro Techniques; Mice; Neuropeptide Y; Olfactory Mucosa; Purinergic Antagonists; Pyridoxal Phosphate; Receptors, Purinergic; Suramin; Uridine Triphosphate | 2009 |
Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
Topics: Adenosine Triphosphate; Adrenergic alpha-1 Receptor Antagonists; Animals; Benzenesulfonates; Calcium Channel Blockers; Calcium Channels, L-Type; Male; Mesenteric Arteries; Mice, Inbred C57BL; Neuropeptide Y; Nifedipine; Prazosin; Receptors, Neuropeptide Y; Receptors, Purinergic P2X1; Suramin; Sympathetic Nervous System; Vasoconstriction | 2021 |